Machine learning-guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance
Source check: Source checked. Not independent scientific confirmation.
Finding: The full text describes harmonized survival modeling across four NSCLC immunotherapy cohorts (156 patients), single-cell analysis and external melanoma-cohort evaluation, followed by functional experiments; it distinguishes predictive association from preclinical mechanism. This record is limited to the study result and does not establish independent replication or real-world benefit.
Technology: AORSF survival model
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- The full text describes harmonized survival modeling across four NSCLC immunotherapy cohorts (156 patients), single-cell analysis and external melanoma-cohort evaluation, followed by functional experiments; it distinguishes predictive association from preclinical mechanism.
- Test and result
- The full text describes harmonized survival modeling across four NSCLC immunotherapy cohorts (156 patients), single-cell analysis and external melanoma-cohort evaluation, followed by functional experiments; it distinguishes predictive association from preclinical mechanism.
- Limitation / still unknown
- No prospective clinical benefit or broader external validity is established by the documented study. Organization affiliation was not available in retrieved Crossref metadata. Organization affiliation was not stated in the source material reviewed. Affiliation was not stated in the reviewed material.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12266572/ · https://europepmc.org/article/MED/40582068 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12266572/#Methods:
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.